LISA ZAMBRANO: Open Payments
NPI 1073559886 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 78 payments from 20 companies in 2025. Trend: 2023 $1,277 · 2024 $1,683 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $256 |
| Janssen Biotech, Inc. | 5 | $242 |
| Medtronic, Inc. | 4 | $238 |
| COLOPLAST CORP | 5 | $174 |
| TOLMAR, INC. | 13 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $155 |
| Dendreon Pharmaceuticals LLC | 4 | $114 |
| PFIZER INC. | 4 | $100 |
| Merck Sharp & Dohme LLC | 3 | $95 |
| Endo USA, Inc. | 4 | $85 |
Products named: ERLEADA, INTERSTIM, ORGOVYX, Nubeqa, Xtandi, SpeediCath, JATENZO, PROVENGE.
Industry payments across TX — which companies pay providers there.
